Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Exploration of 2, 4-diaminopyrimidine and 2, 4-diamino-s-triazine derivatives as potential antifilarial agents.

Identifieur interne : 005786 ( Ncbi/Checkpoint ); précédent : 005785; suivant : 005787

Exploration of 2, 4-diaminopyrimidine and 2, 4-diamino-s-triazine derivatives as potential antifilarial agents.

Auteurs : R D Sharma [Inde] ; S. Bag ; N R Tawari ; M S Degani ; K. Goswami ; M V R. Reddy

Source :

RBID : pubmed:23552564

Descripteurs français

English descriptors

Abstract

In view of the mandate from the World Health Organization (WHO) for developing novel drug candidates against human lymphatic filariasis, dihydrofolate reductase (DHFR) inhibitors are explored as potential antifilarial agents. The in vitro biological evaluation of an in-house library of 12 diverse antifolate compounds with 2,4-diaminopyrimidine and 2,4-diamino-s-triazine structural features against Brugia malayi is reported. To confirm the DHFR inhibitory potential of these compounds, reversal studies using folic acid and folinic acid were undertaken. Inhibition of DHFR can induce apoptosis; in this light, preliminary evidence of apoptosis by test compounds was detected using ethidium bromide-acridine orange staining and the poly(adenosine diphosphate-ribose) polymerase (PARP) inhibition assay. Among the evaluated compounds, 3 showed significant activity against both microfilariae and adult worms. The effects of 2 of these compounds were mostly reversed by folic acid, validating DHFR inhibitory activity. Partial reversal of the effect of 2 compounds by folinic acid and non-reversal of the effect of the third compound both by folic and folinic acids are discussed. This study opens new avenues for the discovery of lead molecules by exploiting the folate pathway against one of the major neglected tropical diseases, filariasis.

DOI: 10.1017/S0031182013000309
PubMed: 23552564


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:23552564

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Exploration of 2, 4-diaminopyrimidine and 2, 4-diamino-s-triazine derivatives as potential antifilarial agents.</title>
<author>
<name sortKey="Sharma, R D" sort="Sharma, R D" uniqKey="Sharma R" first="R D" last="Sharma">R D Sharma</name>
<affiliation wicri:level="1">
<nlm:affiliation>JB Tropical Disease Research Centre and Department of Biochemistry, Mahatma Gandhi Institute of Medical Sciences, Sevagram 442102, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>JB Tropical Disease Research Centre and Department of Biochemistry, Mahatma Gandhi Institute of Medical Sciences, Sevagram 442102</wicri:regionArea>
<wicri:noRegion>Sevagram 442102</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bag, S" sort="Bag, S" uniqKey="Bag S" first="S" last="Bag">S. Bag</name>
</author>
<author>
<name sortKey="Tawari, N R" sort="Tawari, N R" uniqKey="Tawari N" first="N R" last="Tawari">N R Tawari</name>
</author>
<author>
<name sortKey="Degani, M S" sort="Degani, M S" uniqKey="Degani M" first="M S" last="Degani">M S Degani</name>
</author>
<author>
<name sortKey="Goswami, K" sort="Goswami, K" uniqKey="Goswami K" first="K" last="Goswami">K. Goswami</name>
</author>
<author>
<name sortKey="Reddy, M V R" sort="Reddy, M V R" uniqKey="Reddy M" first="M V R" last="Reddy">M V R. Reddy</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:23552564</idno>
<idno type="pmid">23552564</idno>
<idno type="doi">10.1017/S0031182013000309</idno>
<idno type="wicri:Area/PubMed/Corpus">001C08</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001C08</idno>
<idno type="wicri:Area/PubMed/Curation">001C08</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001C08</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001C08</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001C08</idno>
<idno type="wicri:Area/Ncbi/Merge">005786</idno>
<idno type="wicri:Area/Ncbi/Curation">005786</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">005786</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Exploration of 2, 4-diaminopyrimidine and 2, 4-diamino-s-triazine derivatives as potential antifilarial agents.</title>
<author>
<name sortKey="Sharma, R D" sort="Sharma, R D" uniqKey="Sharma R" first="R D" last="Sharma">R D Sharma</name>
<affiliation wicri:level="1">
<nlm:affiliation>JB Tropical Disease Research Centre and Department of Biochemistry, Mahatma Gandhi Institute of Medical Sciences, Sevagram 442102, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>JB Tropical Disease Research Centre and Department of Biochemistry, Mahatma Gandhi Institute of Medical Sciences, Sevagram 442102</wicri:regionArea>
<wicri:noRegion>Sevagram 442102</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bag, S" sort="Bag, S" uniqKey="Bag S" first="S" last="Bag">S. Bag</name>
</author>
<author>
<name sortKey="Tawari, N R" sort="Tawari, N R" uniqKey="Tawari N" first="N R" last="Tawari">N R Tawari</name>
</author>
<author>
<name sortKey="Degani, M S" sort="Degani, M S" uniqKey="Degani M" first="M S" last="Degani">M S Degani</name>
</author>
<author>
<name sortKey="Goswami, K" sort="Goswami, K" uniqKey="Goswami K" first="K" last="Goswami">K. Goswami</name>
</author>
<author>
<name sortKey="Reddy, M V R" sort="Reddy, M V R" uniqKey="Reddy M" first="M V R" last="Reddy">M V R. Reddy</name>
</author>
</analytic>
<series>
<title level="j">Parasitology</title>
<idno type="eISSN">1469-8161</idno>
<imprint>
<date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aedes</term>
<term>Animals</term>
<term>Brugia malayi (drug effects)</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Elephantiasis, Filarial (parasitology)</term>
<term>Female</term>
<term>Filaricides (chemistry)</term>
<term>Filaricides (isolation & purification)</term>
<term>Filaricides (pharmacology)</term>
<term>Folic Acid Antagonists (chemistry)</term>
<term>Folic Acid Antagonists (isolation & purification)</term>
<term>Folic Acid Antagonists (pharmacology)</term>
<term>Gerbillinae</term>
<term>Helminth Proteins (drug effects)</term>
<term>Helminth Proteins (metabolism)</term>
<term>Humans</term>
<term>Inhibitory Concentration 50</term>
<term>Male</term>
<term>Microfilariae</term>
<term>Murinae</term>
<term>Parasitic Sensitivity Tests</term>
<term>Pyrimidines (chemistry)</term>
<term>Pyrimidines (isolation & purification)</term>
<term>Pyrimidines (pharmacology)</term>
<term>Tetrahydrofolate Dehydrogenase (drug effects)</term>
<term>Tetrahydrofolate Dehydrogenase (metabolism)</term>
<term>Triazines (chemistry)</term>
<term>Triazines (isolation & purification)</term>
<term>Triazines (pharmacology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Aedes</term>
<term>Animaux</term>
<term>Antifoliques ()</term>
<term>Antifoliques (isolement et purification)</term>
<term>Antifoliques (pharmacologie)</term>
<term>Brugia malayi ()</term>
<term>Concentration inhibitrice 50</term>
<term>Dihydrofolate reductase ()</term>
<term>Dihydrofolate reductase (métabolisme)</term>
<term>Femelle</term>
<term>Filaricides ()</term>
<term>Filaricides (isolement et purification)</term>
<term>Filaricides (pharmacologie)</term>
<term>Filariose lymphatique (parasitologie)</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Gerbillinae</term>
<term>Humains</term>
<term>Microfilaria</term>
<term>Murinae</term>
<term>Mâle</term>
<term>Protéines d'helminthes ()</term>
<term>Protéines d'helminthes (métabolisme)</term>
<term>Pyrimidines ()</term>
<term>Pyrimidines (isolement et purification)</term>
<term>Pyrimidines (pharmacologie)</term>
<term>Tests de sensibilité parasitaire</term>
<term>Triazines ()</term>
<term>Triazines (isolement et purification)</term>
<term>Triazines (pharmacologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Filaricides</term>
<term>Folic Acid Antagonists</term>
<term>Pyrimidines</term>
<term>Triazines</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Brugia malayi</term>
<term>Helminth Proteins</term>
<term>Tetrahydrofolate Dehydrogenase</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en">
<term>Filaricides</term>
<term>Folic Acid Antagonists</term>
<term>Pyrimidines</term>
<term>Triazines</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr">
<term>Antifoliques</term>
<term>Filaricides</term>
<term>Pyrimidines</term>
<term>Triazines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Helminth Proteins</term>
<term>Tetrahydrofolate Dehydrogenase</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Dihydrofolate reductase</term>
<term>Protéines d'helminthes</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitologie" xml:lang="fr">
<term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitology" xml:lang="en">
<term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Antifoliques</term>
<term>Filaricides</term>
<term>Pyrimidines</term>
<term>Triazines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Filaricides</term>
<term>Folic Acid Antagonists</term>
<term>Pyrimidines</term>
<term>Triazines</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aedes</term>
<term>Animals</term>
<term>Female</term>
<term>Gerbillinae</term>
<term>Humans</term>
<term>Inhibitory Concentration 50</term>
<term>Male</term>
<term>Microfilariae</term>
<term>Murinae</term>
<term>Parasitic Sensitivity Tests</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Aedes</term>
<term>Animaux</term>
<term>Antifoliques</term>
<term>Brugia malayi</term>
<term>Concentration inhibitrice 50</term>
<term>Dihydrofolate reductase</term>
<term>Femelle</term>
<term>Filaricides</term>
<term>Gerbillinae</term>
<term>Humains</term>
<term>Microfilaria</term>
<term>Murinae</term>
<term>Mâle</term>
<term>Protéines d'helminthes</term>
<term>Pyrimidines</term>
<term>Tests de sensibilité parasitaire</term>
<term>Triazines</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">In view of the mandate from the World Health Organization (WHO) for developing novel drug candidates against human lymphatic filariasis, dihydrofolate reductase (DHFR) inhibitors are explored as potential antifilarial agents. The in vitro biological evaluation of an in-house library of 12 diverse antifolate compounds with 2,4-diaminopyrimidine and 2,4-diamino-s-triazine structural features against Brugia malayi is reported. To confirm the DHFR inhibitory potential of these compounds, reversal studies using folic acid and folinic acid were undertaken. Inhibition of DHFR can induce apoptosis; in this light, preliminary evidence of apoptosis by test compounds was detected using ethidium bromide-acridine orange staining and the poly(adenosine diphosphate-ribose) polymerase (PARP) inhibition assay. Among the evaluated compounds, 3 showed significant activity against both microfilariae and adult worms. The effects of 2 of these compounds were mostly reversed by folic acid, validating DHFR inhibitory activity. Partial reversal of the effect of 2 compounds by folinic acid and non-reversal of the effect of the third compound both by folic and folinic acids are discussed. This study opens new avenues for the discovery of lead molecules by exploiting the folate pathway against one of the major neglected tropical diseases, filariasis.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Inde</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Bag, S" sort="Bag, S" uniqKey="Bag S" first="S" last="Bag">S. Bag</name>
<name sortKey="Degani, M S" sort="Degani, M S" uniqKey="Degani M" first="M S" last="Degani">M S Degani</name>
<name sortKey="Goswami, K" sort="Goswami, K" uniqKey="Goswami K" first="K" last="Goswami">K. Goswami</name>
<name sortKey="Reddy, M V R" sort="Reddy, M V R" uniqKey="Reddy M" first="M V R" last="Reddy">M V R. Reddy</name>
<name sortKey="Tawari, N R" sort="Tawari, N R" uniqKey="Tawari N" first="N R" last="Tawari">N R Tawari</name>
</noCountry>
<country name="Inde">
<noRegion>
<name sortKey="Sharma, R D" sort="Sharma, R D" uniqKey="Sharma R" first="R D" last="Sharma">R D Sharma</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005786 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 005786 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:23552564
   |texte=   Exploration of 2, 4-diaminopyrimidine and 2, 4-diamino-s-triazine derivatives as potential antifilarial agents.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i   -Sk "pubmed:23552564" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024